Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlation Between Phenotypic Activity of CYP2C9 and Genetic Polymorphism in CYP2C9 and Warfarin Metabolism.

NCT00162474 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00162474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00162474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlation Between Phenotypic Activity of CYP2C9 and Genetic Polymorphism in CYP2C9 and Warfarin Metabolism.
Lead sponsor
Hadassah Medical Organization
Phase
Not applicable
Overall status
Recruiting
Start date
September 30, 2003
Completion date
December 31, 2030
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy